20.02.2014 - German pharmaceutical producer Boehringer Ingelheim is being confronted in the U.S. with more than 2,000 lawsuits related to its blood thinner Pradaxa (dabigatran). The plaintiffs...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)